LifeStance Health (LFST) Income towards Parent Company (2020 - 2026)

LifeStance Health has disclosed Income towards Parent Company across 7 years of filings, most recently posting $14.2 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 1908.89% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $25.2 million (up 170.76% YoY), while the FY2025 annual figure was $11.7 million, up 120.33% from the prior year.
• Income towards Parent Company improved to $14.2 million in Q1 2026, from $13.7 million in the prior quarter.
• Over the last five years, Income towards Parent Company for LFST reached as high as $14.2 million in Q1 2026 and fell as low as -$68.7 million in Q2 2022.
• The 5-year median for Income towards Parent Company is -$23.3 million (2024), against an average of -$25.5 million.
• Annual changes were most pronounced in 2022 — Income towards Parent Company sank 617.9% — and 2026, when it soared 1908.89%.
• A 5-year view of Income towards Parent Company shows it stood at -$46.7 million in 2022, then increased by 3.64% to -$45.0 million in 2023, then soared by 84.18% to -$7.1 million in 2024, then soared by 292.44% to $13.7 million in 2025, then increased by 4.07% to $14.2 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $14.2 million, $13.7 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.